Inventor · disambiguated record
Ravi Kumar Jalluri
Also filed as: JALLURI RAVI K · JALLURI RAVI KUMAR
20 granted patents·8 pending applications·337 citations·filing 2000–2025
95Inventor score
Files withINCYTE CORP14COGENT BIOSCIENCES INC6RODGERS JAMES D2SIGNAL PHARM INC2LABAUDINIERE RICHARD F1
Top patents by PatentIndex Score
28 records- 0198US8415362B2Pyrazolyl substituted pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitorsRODGERS JAMES D·Filed 2008·Granted Apr 9, 2013·117 cites·21 claims
- 0297US10065963B2Heterocyclic compounds as PI3K-γ inhibitorsINCYTE CORP·Filed 2016·Granted Sep 4, 2018·16 cites·14 claims
- 0396US10472368B2Heterocyclic compounds as PI3K-γ inhibitorsINCYTE CORP·Filed 2018·Granted Nov 12, 2019·12 cites·28 claims
- 0495US11225486B2Tertiary alcohols as PI3K-γ inhibitorsINCYTE CORP·Filed 2020·Granted Jan 18, 2022·4 cites·51 claims
- 0594US7683060B2Triazolotriazines as kinase inhibitorsINCYTE CORP·Filed 2007·Granted Mar 23, 2010·25 cites·152 claims
- 0693US11926630B2Tertiary alcohols as PI3K-γ inhibitorsINCYTE CORP·Filed 2021·Granted Mar 12, 2024·2 cites·2 claims
- 0791US6610684B2Fused azepinone cyclin dependent kinase inhibitorsUS HEALTH·Filed 2000·Granted Aug 26, 2003·53 cites·30 claims
- 0891US6291456B1Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM INC·Filed 2000·Granted Sep 18, 2001·62 cites·78 claims
- 0988US10738057B2Tertiary alcohols as PI3K-γ inhibitorsINCYTE CORP·Filed 2018·Granted Aug 11, 2020·5 cites·38 claims
- 1086US11091491B2Heterocyclic compounds as PI3K-y inhibitorsINCYTE CORP·Filed 2019·Granted Aug 17, 2021·4 cites·37 claims
- 1185US8143251B2Triazolotriazines as kinase inhibitorsZHUO JINCONG·Filed 2011·Granted Mar 27, 2012·7 cites·17 claims
- 1284US7915408B2Triazolotriazines as kinase inhibitorsINCYTE CORP·Filed 2010·Granted Mar 29, 2011·6 cites·29 claims
- 1380US6372739B1Compounds and methods for modulation of estrogen receptorsSIGNAL PHARM INC·Filed 2001·Granted Apr 16, 2002·13 cites·20 claims
- 1479US7973041B2Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinasesINCYTE CORP·Filed 2008·Granted Jul 5, 2011·2 cites·11 claims
- 1578US7491724B2Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinasesINCYTE CORP·Filed 2004·Granted Feb 17, 2009·8 cites·10 claims
- 1675US11773102B2Heterocyclic compounds as PI3K-γ inhibitorsINCYTE CORP·Filed 2021·Granted Oct 3, 2023·0 cites·27 claims
- 1771US8853243B2Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinasesLI YUN-LONG·Filed 2011·Granted Oct 7, 2014·1 cites·12 claims
- 1868US12351581B2Compounds for FGFR inhibitionCOGENT BIOSCIENCES INC·Filed 2024·Granted Jul 8, 2025·0 cites·30 claims
- 1967US12281122B1PI3K inhibitorsCOGENT BIOSCIENCES INC·Filed 2024·Granted Apr 22, 2025·0 cites·30 claims
- 2063US9440958B2Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinasesINCYTE CORP·Filed 2014·Granted Sep 13, 2016·0 cites·9 claims
- 2161US2009215766A1Tetracyclic inhibitors of janus kinasesINCYTE CORP·Filed 2008·Application pending·0 cites
- 2258US2025270211A1Compounds for fgfr inhibitionCOGENT BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 2356US2024270741A1Compounds for fgfrs inhibitorsCOGENT BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2453US2006106020A1Tetracyclic inhibitors of Janus kinasesRODGERS JAMES D·Filed 2005·Application pending·0 cites
- 2553US2025129078A1Erbb2 inhibitorsCOGENT BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2648US2025206752A1Pi3k inhibitorsCOGENT BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 2744US2013137681A1HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORSINCYTE CORP·Filed 2013·Application pending·0 cites
- 2842US2006287351A1Antibiotic cycloalkyltetrahydroquinoline derivativesLABAUDINIERE RICHARD F·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ravi Kumar Jalluri files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →